Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 27, 2026	Mar. 28, 2025
Cash flows from operating activities:
Net earnings	$ 1,029	$ 954
Noncash items:
Depreciation	193	181
Amortization of intangible assets	434	410
Stock-based compensation expense	58	61
Investment losses and pretax gain on sale of product line	77	81
Impairment charges	0	15
Change in trade accounts receivable, net	66	89
Change in inventories	(132)	(166)
Change in trade accounts payable	(41)	(61)
Change in prepaid expenses and other assets	(40)	(32)
Change in accrued expenses and other liabilities	(322)	(233)
Net cash provided by operating activities	1,322	1,299
Cash flows from investing activities:
Payments for additions to property, plant and equipment	(237)	(245)
Proceeds from sales of property, plant and equipment	0	6
Payments for purchases of investments	(20)	(18)
Proceeds from sales of investments	0	5
Proceeds from sale of product line	0	9
All other investing activities	8	1
Total cash used in investing activities	(249)	(242)
Cash flows from financing activities:
Payments for the issuance of common stock in connection with stock-based compensation, net	(9)	(5)
Payment of dividends	(226)	(194)
Net proceeds from (repayments of) borrowings (maturities of 90 days or less)	1,743	(3)
Borrowings (maturities longer than 90 days)	0	4
Repayments of borrowings (maturities longer than 90 days)	(1,434)	0
Payments for repurchase of common stock	0	(1,078)
All other financing activities	(28)	21
Total cash provided by (used in) financing activities	46	(1,255)
Effect of exchange rate changes on cash and equivalents	(33)	113
Net change in cash and equivalents	1,086	(85)
Beginning balance of cash and equivalents	4,615	2,078
Ending balance of cash and equivalents	5,701	1,993
Supplemental disclosures:
Cash interest payments	28	63
Cash income tax payments	$ 191	$ 201